Interesting Facts about Namenda

Forest Laboratories Inc. and also Merz: “A drug called Namenda was approved by the FDA in order to treat severe and moderate dementia of the Alzheimer type.” This medication is 28mg extended-release pills. The safety of its intake was proved by a trial period that was controlled by using placebo and taken on 600 patients who were already taking some cholinesterase inhibitor. Achieved results actually claim that these patients who were treated by these pills experienced significant improvements in their medical conditions and cognition when compared to placebo.

In addition, this company also owns some patent applications that are related to this medication and are still pending. Namenda will be covered by a special patent that expires in 2015. This company is now determining a proper commercial strategy and market timing in order to guarantee a successful result in the end. This drug is represented by extended-release pills that are approved for the treatment of dementia. The first formula of such a drug was approved in 2003. It has a certain plan of functions that mainly focuses on the target to treat Alzheimer’s disease and glutamate pathway. 

Besides, it is a popular prescription medication utilized to eliminate the chemicals in one’s brain that may lead to the development of different symptoms common for Alzheimer’s disease. The main active ingredient of Namenda is memantine. It is utilized to treat severe and moderate confusion that are related to this ailment. This drug is effective not only in curing this medical condition, but it also can improve the ability to do a number of daily functions, memory and awareness of those patients who take it. 

Namenda actually functions by blocking one certain natural substance in a patient’s brain. So this medication can be used for other purposes as it is prescribed by a doctor. However, it may have some certain contraindications as well. It is contraindicated in those people who have hypersensitivity to active components that are used to produce this drug. It is also necessary to know about other precautions before stating to use it. 

Forest Laboratories: “Caregivers must be instructed about the dosage escalation and recommended administration. Namenda has not been evaluated on a regular basis in those patients who have a seizure disorder.” In addition, this medication should be taken with a certain caution and under circumstances that can raise a pH level of urine. Alkaline urine conditions can eliminate memantine, which results in boosted plasma levels in the end.